APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Adhesive Liquid Embolic Agents

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-Adhesive Liquid Embolic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025182 pages

Choose your research edition.

Industry ResearchNon-Adhesive Liquid Embolic Agents Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Adhesive Liquid Embolic Agents Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Non-Adhesive Liquid Embolic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Adhesive Liquid Embolic Agents Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Adhesive Liquid Embolic Agents Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Non-Adhesive Liquid Embolic Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Non-Adhesive Liquid Embolic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-Adhesive Liquid Embolic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Adhesive Liquid Embolic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-Adhesive Liquid Embolic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-Adhesive Liquid Embolic Agents include BlackSwan Vascular, Success Bio-Tech, Johnson & Johnson, Medtronic, Meril Life and Balt Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-Adhesive Liquid Embolic Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-Adhesive Liquid Embolic Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-Adhesive Liquid Embolic Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-Adhesive Liquid Embolic Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-Adhesive Liquid Embolic Agents Segment by Company

BlackSwan Vascular

Success Bio-Tech

Johnson & Johnson

Medtronic

Meril Life

Balt Group

Non-Adhesive Liquid Embolic Agents Segment by Type

EVOH-Based

Diluted Cyanoacrylate

Others

Non-Adhesive Liquid Embolic Agents Segment by Application

Brain Arterio-Venous Malformations (bAVM)

Tumor Embolization

Others

Non-Adhesive Liquid Embolic Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Adhesive Liquid Embolic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Adhesive Liquid Embolic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Adhesive Liquid Embolic Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-Adhesive Liquid Embolic Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-Adhesive Liquid Embolic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non-Adhesive Liquid Embolic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non-Adhesive Liquid Embolic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Non-Adhesive Liquid Embolic Agents Industry Trends Table 2. Non-Adhesive Liquid Embolic Agents Industry Drivers Table 3. Non-Adhesive Liquid Embolic Agents Industry Opportunities and Challenges Table 4. Non-Adhesive Liquid Embolic Agents Industry Restraints Table 5. Global Non-Adhesive Liquid Embolic Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Non-Adhesive Liquid Embolic Agents Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Manufacturers Table 9. Global Non-Adhesive Liquid Embolic Agents Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Non-Adhesive Liquid Embolic Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Non-Adhesive Liquid Embolic Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Non-Adhesive Liquid Embolic Agents Manufacturers, Product Type & Application Table 13. Global Non-Adhesive Liquid Embolic Agents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-Adhesive Liquid Embolic Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of EVOH-Based Table 17. Major Manufacturers of Diluted Cyanoacrylate Table 18. Major Manufacturers of Others Table 19. Global Non-Adhesive Liquid Embolic Agents Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2026) & (K Units) Table 21. Global Non-Adhesive Liquid Embolic Agents Sales by Type (2027-2032) & (K Units) Table 22. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2026) Table 23. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2027-2032) Table 24. Global Non-Adhesive Liquid Embolic Agents Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Non-Adhesive Liquid Embolic Agents Revenue by Type (2021-2026) & (K Units) Table 26. Global Non-Adhesive Liquid Embolic Agents Revenue by Type (2027-2032) & (K Units) Table 27. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Type (2021-2026) Table 28. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Brain Arterio-Venous Malformations (bAVM) Table 30. Major Manufacturers of Tumor Embolization Table 31. Major Manufacturers of Others Table 32. Global Non-Adhesive Liquid Embolic Agents Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2026) & (K Units) Table 34. Global Non-Adhesive Liquid Embolic Agents Sales by Application (2027-2032) & (K Units) Table 35. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Application (2021-2026) Table 36. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Application (2027-2032) Table 37. Global Non-Adhesive Liquid Embolic Agents Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Non-Adhesive Liquid Embolic Agents Revenue by Application (2021-2026) & (K Units) Table 39. Global Non-Adhesive Liquid Embolic Agents Revenue by Application (2027-2032) & (K Units) Table 40. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Application (2021-2026) Table 41. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Application (2027-2032) Table 42. Global Non-Adhesive Liquid Embolic Agents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Non-Adhesive Liquid Embolic Agents Sales by Region (2021-2026) & (K Units) Table 44. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Region (2021-2026) Table 45. Global Non-Adhesive Liquid Embolic Agents Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Non-Adhesive Liquid Embolic Agents Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Non-Adhesive Liquid Embolic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026) & (K Units) Table 49. North America Non-Adhesive Liquid Embolic Agents Sales by Country (2027-2032) & (K Units) Table 50. Europe Non-Adhesive Liquid Embolic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026) & (K Units) Table 52. Europe Non-Adhesive Liquid Embolic Agents Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Non-Adhesive Liquid Embolic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Non-Adhesive Liquid Embolic Agents Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Non-Adhesive Liquid Embolic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Non-Adhesive Liquid Embolic Agents Sales by Country (2027-2032) & (K Units) Table 59. Global Non-Adhesive Liquid Embolic Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Non-Adhesive Liquid Embolic Agents Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Non-Adhesive Liquid Embolic Agents Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Region (2021-2026) Table 63. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Region (2027-2032) Table 64. BlackSwan Vascular Company Information Table 65. BlackSwan Vascular Business Overview Table 66. BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Product Portfolio Table 68. BlackSwan Vascular Recent Development Table 69. Success Bio-Tech Company Information Table 70. Success Bio-Tech Business Overview Table 71. Success Bio-Tech Non-Adhesive Liquid Embolic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Success Bio-Tech Non-Adhesive Liquid Embolic Agents Product Portfolio Table 73. Success Bio-Tech Recent Development Table 74. Johnson & Johnson Company Information Table 75. Johnson & Johnson Business Overview Table 76. Johnson & Johnson Non-Adhesive Liquid Embolic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Johnson & Johnson Non-Adhesive Liquid Embolic Agents Product Portfolio Table 78. Johnson & Johnson Recent Development Table 79. Medtronic Company Information Table 80. Medtronic Business Overview Table 81. Medtronic Non-Adhesive Liquid Embolic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Medtronic Non-Adhesive Liquid Embolic Agents Product Portfolio Table 83. Medtronic Recent Development Table 84. Meril Life Company Information Table 85. Meril Life Business Overview Table 86. Meril Life Non-Adhesive Liquid Embolic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Meril Life Non-Adhesive Liquid Embolic Agents Product Portfolio Table 88. Meril Life Recent Development Table 89. Balt Group Company Information Table 90. Balt Group Business Overview Table 91. Balt Group Non-Adhesive Liquid Embolic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Balt Group Non-Adhesive Liquid Embolic Agents Product Portfolio Table 93. Balt Group Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Non-Adhesive Liquid Embolic Agents Distributors List Table 97. Non-Adhesive Liquid Embolic Agents Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Non-Adhesive Liquid Embolic Agents Product Image Figure 2. Global Non-Adhesive Liquid Embolic Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Adhesive Liquid Embolic Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-Adhesive Liquid Embolic Agents Sales (2021-2032) & (K Units) Figure 5. Global Non-Adhesive Liquid Embolic Agents Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Non-Adhesive Liquid Embolic Agents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. EVOH-Based Image Figure 9. Diluted Cyanoacrylate Image Figure 10. Others Image Figure 11. Global Non-Adhesive Liquid Embolic Agents Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Non-Adhesive Liquid Embolic Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2032) Figure 14. Global Non-Adhesive Liquid Embolic Agents Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Type (2021-2032) Figure 17. Brain Arterio-Venous Malformations (bAVM) Image Figure 18. Tumor Embolization Image Figure 19. Others Image Figure 20. Global Non-Adhesive Liquid Embolic Agents Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Non-Adhesive Liquid Embolic Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Application (2021-2032) Figure 23. Global Non-Adhesive Liquid Embolic Agents Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Application (2021-2032) Figure 26. North America Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Non-Adhesive Liquid Embolic Agents Sales Market Share by Country (2021-2032) Figure 28. U.S. Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Non-Adhesive Liquid Embolic Agents Sales Market Share by Country (2021-2032) Figure 33. Germany Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Non-Adhesive Liquid Embolic Agents Sales Market Share by Country (2021-2032) Figure 40. China Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Non-Adhesive Liquid Embolic Agents Sales Market Share by Country (2021-2032) Figure 48. Brazil Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Non-Adhesive Liquid Embolic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Non-Adhesive Liquid Embolic Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Non-Adhesive Liquid Embolic Agents Revenue (2021-2032) & (US$ Million) Figure 59. North America Non-Adhesive Liquid Embolic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Non-Adhesive Liquid Embolic Agents Revenue (2021-2032) & (US$ Million) Figure 61. Europe Non-Adhesive Liquid Embolic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Non-Adhesive Liquid Embolic Agents Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Non-Adhesive Liquid Embolic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Non-Adhesive Liquid Embolic Agents Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Non-Adhesive Liquid Embolic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Non-Adhesive Liquid Embolic Agents Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Non-Adhesive Liquid Embolic Agents Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • EVOH-Based
  • Diluted Cyanoacrylate
  • Others
Applications
  • Brain Arterio-Venous Malformations (bAVM)
  • Tumor Embolization
  • Others
Companies covered
  • BlackSwan Vascular
  • Success Bio-Tech
  • Johnson & Johnson
  • Medtronic
  • Meril Life
  • Balt Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-Adhesive Liquid Embolic Agents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-Adhesive Liquid Embolic Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Non-Adhesive Liquid Embolic Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Non-Adhesive Liquid Embolic Agents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Non-Adhesive Liquid Embolic Agents Market Dynamics
  1. 2.1 Non-Adhesive Liquid Embolic Agents Industry Trends
  2. 2.2 Non-Adhesive Liquid Embolic Agents Industry Drivers
  3. 2.3 Non-Adhesive Liquid Embolic Agents Industry Opportunities and Challenges
  4. 2.4 Non-Adhesive Liquid Embolic Agents Industry Restraints
3 Non-Adhesive Liquid Embolic Agents Market by Manufacturers
  1. 3.1 Global Non-Adhesive Liquid Embolic Agents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Non-Adhesive Liquid Embolic Agents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Non-Adhesive Liquid Embolic Agents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Non-Adhesive Liquid Embolic Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-Adhesive Liquid Embolic Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Non-Adhesive Liquid Embolic Agents Manufacturers, Product Type & Application
  7. 3.7 Global Non-Adhesive Liquid Embolic Agents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-Adhesive Liquid Embolic Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-Adhesive Liquid Embolic Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-Adhesive Liquid Embolic Agents Tier 1, Tier 2, and Tier 3
4 Non-Adhesive Liquid Embolic Agents Market by Type
  1. 4.1 Non-Adhesive Liquid Embolic Agents Type Introduction
  2. 4.1.1 EVOH-Based
  3. 4.1.2 Diluted Cyanoacrylate
  4. 4.1.3 Others
  5. 4.2 Global Non-Adhesive Liquid Embolic Agents Sales by Type
  6. 4.2.1 Global Non-Adhesive Liquid Embolic Agents Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Non-Adhesive Liquid Embolic Agents Sales by Type (2021-2032)
  8. 4.2.3 Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2021-2032)
  9. 4.3 Global Non-Adhesive Liquid Embolic Agents Revenue by Type
  10. 4.3.1 Global Non-Adhesive Liquid Embolic Agents Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Non-Adhesive Liquid Embolic Agents Revenue by Type (2021-2032)
  12. 4.3.3 Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Type (2021-2032)
5 Non-Adhesive Liquid Embolic Agents Market by Application
  1. 5.1 Non-Adhesive Liquid Embolic Agents Application Introduction
  2. 5.1.1 Brain Arterio-Venous Malformations (bAVM)
  3. 5.1.2 Tumor Embolization
  4. 5.1.3 Others
  5. 5.2 Global Non-Adhesive Liquid Embolic Agents Sales by Application
  6. 5.2.1 Global Non-Adhesive Liquid Embolic Agents Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-Adhesive Liquid Embolic Agents Sales by Application (2021-2032)
  8. 5.2.3 Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Application (2021-2032)
  9. 5.3 Global Non-Adhesive Liquid Embolic Agents Revenue by Application
  10. 5.3.1 Global Non-Adhesive Liquid Embolic Agents Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Non-Adhesive Liquid Embolic Agents Revenue by Application (2021-2032)
  12. 5.3.3 Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Application (2021-2032)
6 Global Non-Adhesive Liquid Embolic Agents Sales by Region
  1. 6.1 Global Non-Adhesive Liquid Embolic Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-Adhesive Liquid Embolic Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Non-Adhesive Liquid Embolic Agents Sales by Region (2021-2026)
  4. 6.2.2 Global Non-Adhesive Liquid Embolic Agents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-Adhesive Liquid Embolic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Non-Adhesive Liquid Embolic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Non-Adhesive Liquid Embolic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Non-Adhesive Liquid Embolic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Non-Adhesive Liquid Embolic Agents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Non-Adhesive Liquid Embolic Agents Revenue by Region
  1. 7.1 Global Non-Adhesive Liquid Embolic Agents Revenue by Region
  2. 7.1.1 Global Non-Adhesive Liquid Embolic Agents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Non-Adhesive Liquid Embolic Agents Revenue by Region (2021-2026)
  4. 7.1.3 Global Non-Adhesive Liquid Embolic Agents Revenue by Region (2027-2032)
  5. 7.1.4 Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Non-Adhesive Liquid Embolic Agents Revenue (2021-2032)
  8. 7.2.2 North America Non-Adhesive Liquid Embolic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Non-Adhesive Liquid Embolic Agents Revenue (2021-2032)
  11. 7.3.2 Europe Non-Adhesive Liquid Embolic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Non-Adhesive Liquid Embolic Agents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Non-Adhesive Liquid Embolic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Non-Adhesive Liquid Embolic Agents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Non-Adhesive Liquid Embolic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BlackSwan Vascular
  2. 8.1.1 BlackSwan Vascular Company Information
  3. 8.1.2 BlackSwan Vascular Business Overview
  4. 8.1.3 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Product Portfolio
  6. 8.1.5 BlackSwan Vascular Recent Developments
  7. 8.2 Success Bio-Tech
  8. 8.2.1 Success Bio-Tech Company Information
  9. 8.2.2 Success Bio-Tech Business Overview
  10. 8.2.3 Success Bio-Tech Non-Adhesive Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Success Bio-Tech Non-Adhesive Liquid Embolic Agents Product Portfolio
  12. 8.2.5 Success Bio-Tech Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Non-Adhesive Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Non-Adhesive Liquid Embolic Agents Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Medtronic
  20. 8.4.1 Medtronic Company Information
  21. 8.4.2 Medtronic Business Overview
  22. 8.4.3 Medtronic Non-Adhesive Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Medtronic Non-Adhesive Liquid Embolic Agents Product Portfolio
  24. 8.4.5 Medtronic Recent Developments
  25. 8.5 Meril Life
  26. 8.5.1 Meril Life Company Information
  27. 8.5.2 Meril Life Business Overview
  28. 8.5.3 Meril Life Non-Adhesive Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Meril Life Non-Adhesive Liquid Embolic Agents Product Portfolio
  30. 8.5.5 Meril Life Recent Developments
  31. 8.6 Balt Group
  32. 8.6.1 Balt Group Company Information
  33. 8.6.2 Balt Group Business Overview
  34. 8.6.3 Balt Group Non-Adhesive Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Balt Group Non-Adhesive Liquid Embolic Agents Product Portfolio
  36. 8.6.5 Balt Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-Adhesive Liquid Embolic Agents Value Chain Analysis
  2. 9.1.1 Non-Adhesive Liquid Embolic Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-Adhesive Liquid Embolic Agents Production Mode & Process
  6. 9.2 Non-Adhesive Liquid Embolic Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-Adhesive Liquid Embolic Agents Distributors
  9. 9.2.3 Non-Adhesive Liquid Embolic Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst